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Patients with diabetes mellitus (DM) are especially vulnerable 
to hypertensive injury. The coexistence with arterial hypertension 
(AH) has a significant impact of the poor prognosis for patients with 
DM because of its effect on the micro and macro vasculature.  
Diabetic nephropathy is the leading cause of chronic kidney 
disease. It is also one of the most significant long-term complications 
of morbidity and mortality for individual patients with DM. There is 
the connection between AH and microalbuminuria, which is now 
recognized as an independent cardiac risk factor, even in the absence 
of diabetes. On the other hand, blood pressure levels, and genetic 
predisposition are the main risk factors for the development of 
diabetic nephropathy. 
Epidemiologic and experimental evidence suggests that 
serum uric acid (UA) is a marker of developing hypertension. 
Furthermore, hyperuricemia is a true risk factor of chronic kidney 
disease. Anyway, uric acid could be a prognostic marker of events 
including myocardial infarction, heart failure, stroke and death. 
The purpose of our study was the determination of 
interconnection between the level of serum uric acid and albumin to 
creatinine ratio (ACR) in urine for prevention cardiovascular 
complications in patients with type 2 DM and concomitant AH. 
Participants and methods. We examined 82 patients with type 
2 DM and AH during our clinical treatment. They were treated in 
Sumy City Clinical Hospital № 1  from October 1, 2015 to  February 
15, 2016. Participants were divided in two groups according to the 
level of ACR in urine. 
People from the first (I) group had the normal albuminuria 
(ACR < 30 mg/g). Microalbuminuria was detected in the second (II) 
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group (30 mg/g < ACR < 299 mg/g). Nobody had macroalbuminuria 
(ACR > 300 mg/g). We use this biochemical method of diagnostic 
albuminuria as ACR because of its accuracy. However, the high cost 
is the main  disadvantage of this method. The definition of ACR is 
more expensive than the measuring of albumin concentration in 
urine. Furthermore, the level of ACR is an established marker of 
cardiovascular and cerebrovascular events for patients with type 2 
DM. All participants in this group had the third stage of AH.  
All data were analyzed with the help of statistical methods 
(Excel 2007). In addition, we evaluated the Student criteria (t) and 
the veracity of differences (p) for assessment results. 
In conclusion, we compared  the level of ACR and UA. 
Results. The mean duration of DM was (7,5±1,5) years for 
the I group and the (12±1,1) years for the II group, t = 2,42; p < 0,05. 
Despite, AH was diagnosed during (8,6±1,07) years and (17±0,95) 
years, t = 5,87; p < 0,001 for patients from the I and II group 
respectively. The mean levels of ACR were (28,56±2,1) mg/g and 
(150,79±23,76) mg/g, t = 5,12; p < 0,001, of uric acid – (290±20,6) 
umol/L and (408±36,4) umol/L, t = 2,82; p < 0,01 for participants 
from the I and II group respectively. So, patients with higher ACR 
had the biggest level of UA. In addition, people with 
microalbuminuria had the higher duration of DM and AH. 
In our clinical treatment we determined the interrelation 
between two risk factors of cardiovascular and cerebrovascular 
events such as ACR and UA. It is doubt, that the evaluation of them 
must be necessary for all patients with DM and concomitant AH  to 
prevention complications and mortality.  
Some people say that UA is a predictor of microalbuminuria 
of diabetes. In our clinical trial this aspect was not highlighted, 
because there was no data what was the primary, up rise of UA or of 
ACR. May be it will become clear later. 
 
 
 
 
 
